News
Motif Bio PLC - REVIVE-2 Study Results Published in Journal
RNS Number: 6359 M Motif Bio PLC 01 May 2018 Motif Bio plc. Motif Bio REVIVE-2 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal,. ·Iclaprim met the primary endpoint.
RNS Number: 6359 M Motif Bio PLC 01 May 2018 Motif Bio plc. Motif Bio REVIVE-2 Phase 3 Study Results with Iclaprim Published in Peer-reviewed Journal,. ·Iclaprim met the primary endpoint.